MoneyWorks4Me

Hester Biosciences informs about outcome of board meeting

29 May 2021 Evaluate
Pursuant to the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Hester Biosciences has informed that Board of Directors, in its Meeting held today, have approved the constitution of Risk Management Committee of the Board and formulation of Risk Management Policy. The Board Meeting commenced at 10:45 am and concluded at 11:00 am.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1748.90
Dr. Reddys Labs. 1214.10
Cipla 1312.85
Lupin 1954.80
Zydus Lifesciences 1124.00
View more..